Predictions
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€1.08
27.11.23
27.11.23
€2.00
27.11.24
27.11.24
-0.74%
09.12.23
09.12.23
positive Cash Flow expected
Good rating
Valuable balance sheet
Very capable Management
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€1.03
25.11.23
25.11.23
€0.000
25.11.24
25.11.24
4.26%
09.12.23
09.12.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€1.23
14.11.23
14.11.23
-
14.12.26
14.12.26
-84.64%
05.12.24
05.12.24
Increased challenges to pay loans and raise capital
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€2.14
11.11.23
11.11.23
€1.00
11.11.24
11.11.24
-51.78%
25.11.23
25.11.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€1.95
30.10.23
30.10.23
-
30.10.24
30.10.24
-47.23%
19.01.24
19.01.24
Probably not worthwhile Investment
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€3.43
16.09.23
16.09.23
€1.00
16.09.24
16.09.24
-17.66%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€6.88
08.10.22
08.10.22
€12.00
08.10.23
08.10.23
6.28%
16.10.22
16.10.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€8.93
30.08.22
30.08.22
€10.00
30.08.23
30.08.23
-68.87%
31.08.23
31.08.23
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€12.48
05.02.22
05.02.22
€24.00
05.02.23
05.02.23
13.78%
19.02.22
19.02.22
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€13.86
31.01.22
31.01.22
€42.00
31.01.23
31.01.23
-9.96%
05.02.22
05.02.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Mainz Biomed B.v.
Start price
Target price
Perf. (%)
€23.60
22.01.22
22.01.22
€40.00
22.01.23
22.01.23
-47.12%
05.02.22
05.02.22







